PXL Sapphire 318
Corneal Cross Linking Corneal Cross Linking (CXL) is a treatment with the aim of strengthening the corneal stromal tissue through the formation of new chemical bonds between stromal fibres.
CXL is the only effective non-invasive treatment to stop progressive keratoconus as well as related ectatic disorders (such as PMD and iatrogenic ectasia) and has a regularisation effect on corneal topography. In addition to its role in treating ectatic corneal diseases, CXL has an established place in the management of infectious keratitis. UV light has long been known for its ability to kill different microorganisms (such as bacterial and fungal ones).Since keratitis in humans isan important cause of blindness, and antibiotic resistance is an increasing problem worldwide, CXL proves to be an extremely valuable possibility to manage the condition with a satisfactory outcome. CXL treatments are inexpensive, easy to perform, and easy for the patient.
- 3 - 9 - 18 MW
- Special optics homogenizing the beam
- Continuously adjustable aperture from 3 - 12 mm
- Portable system with table mount allowing full mobility
- Progressive Keratoconus
- Iatrogenic Ectasia
- Pellucid Marginal Degeneration